Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Ineffable Intelligence, a British AI lab founded a mere few months ago by former DeepMind researcher David Silver, has raised $1.1 billion in funding at a valuation of $5.1 billion.

BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to ...

According to MarketsandMarketstm, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to USD 69.34 billion by 2031, at a CAGR of ...

According to MarketsandMarkets™, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to ...

Scientists have developed a new AI method that can work backward from patterns to uncover the hidden processes driving them.

A ripple tells you something happened, but not exactly what. That is the core problem behind a hard class of equations that scientists use when they try to work backward from what they can measure to ...

A good set of scripts lets you avoid the terminal for common tasks ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...